USANA Health Sciences, Inc. (FRA:USJ)

Germany flag Germany · Delayed Price · Currency is EUR
16.50
-0.50 (-2.94%)
Last updated: Dec 5, 2025, 8:04 AM CET
-54.17%
Market Cap 312.24M
Revenue (ttm) 780.52M
Net Income (ttm) 14.53M
Shares Out n/a
EPS (ttm) 0.77
PE Ratio 21.49
Forward PE 10.38
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 16.50
Previous Close 17.00
Day's Range 16.50 - 16.50
52-Week Range 15.70 - 36.00
Beta n/a
RSI 50.89
Earnings Date Feb 3, 2026

About USANA Health Sciences

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Direct selling and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal... [Read more]

Industry Pharmaceutical Preparations
Founded 1992
Employees 1,700
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol USJ
Full Company Profile

Financial Performance

In 2024, USANA Health Sciences's revenue was $854.50 million, a decrease of -7.22% compared to the previous year's $921.01 million. Earnings were $42.03 million, a decrease of -34.11%.

Financial numbers in USD Financial Statements

News

There is no news available yet.